India’s Serum Institute to raise output to 100 mln AstraZeneca doses by July, not end-May

1 minute read

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas

Register now for FREE unlimited access to Reuters.com

NEW DELHI, April 21 (Reuters) - The Serum Institute of India will be able to raise its monthly output of the AstraZeneca COVID-19 vaccine to 100 million doses by July from 60-70 million now, later than a previous timeline of end-May, its chief executive Adar Poonawalla told CNBC-TV18.

Register now for FREE unlimited access to Reuters.com
Reporting by Chandini Monappa and Krishna N. Das; Editing by Andrew Heavens

Our Standards: The Thomson Reuters Trust Principles.